|
Resolution: standard / high Figure 2.
The cumulative incidence function with death as a competing risk for time from eligibility
of therapy to HAART initiation stratified by gender.
Thorsteinsson et al. BMC Infectious Diseases 2012 12:293 doi:10.1186/1471-2334-12-293 |
